共 50 条
- [1] Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2123 - 2132Dimopoulos, MeletiosSpencer, AndrewAttal, MichaelPrince, H. MilesHarousseau, Jean-LucDmoszynska, AnnaSan Miguel, JesusHellmann, AndrzejFacon, ThierryFoa, RobinCorso, AlessandroMasliak, ZvenyslavaOlesnyckyj, MartaYu, ZhinuanPatin, JohnZeldis, Jerome B.Knight, Robert D.
- [2] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma[J]. Nature Clinical Practice Oncology, 2008, 5 : 374 - 375Nikhil C MunshiConstantine MitsiadesPaul G RichardsonKenneth C Anderson
- [3] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma[J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07): : 374 - 375Munshi, Nikhil C.Mitsiades, ConstantineRichardson, Paul G.Anderson, Kenneth C.
- [4] Erratum: Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma[J]. Nature Clinical Practice Oncology, 2008, 5 : 493 - 493Nikhil C MunshiConstantine MitsiadesPaul G RichardsonKenneth C Anderson
- [5] Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma[J]. International Journal of Hematology, 2010, 92 : 118 - 126Shinsuke IidaTakaaki ChouShinichiro OkamotoHirokazu NagaiKiyohiko HatakeHirokazu MurakamiToshiyuki TakagiKazuyuki ShimizuHenry LauKenichi TakeshitaMasaaki TakatokuTomomitsu Hotta
- [7] Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (01) : 118 - 126Iida, ShinsukeChou, TakaakiOkamoto, ShinichiroNagai, HirokazuHatake, KiyohikoMurakami, HirokazuTakagi, ToshiyukiShimizu, KazuyukiLau, HenryTakeshita, KenichiTakatoku, MasaakiHotta, Tomomitsu
- [8] Efficacy of lenalidomide plus dexamethasone in relapsed/refractory multiple myeloma: A systematic review[J]. ANNALS OF ONCOLOGY, 2022, 33 : S489 - S489Tandy, FeniaHadisurya, AudreySuciningtias, MarlynChrystelle, CelineKurniawan, Andree
- [9] Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (02) : 164 - 170Chen, ChristineReece, Donna E.Siegel, DavidNiesvizky, RubenBoccia, Ralph V.Stadtmauer, Edward A.Abonour, RafatRichardson, PaulMatous, JeffreyKumar, ShajiBahlis, Nizar J.Alsina, MelissaVescio, RobertCoutre, Steven E.Pietronigro, DennisKnight, Robert D.Zeldis, Jerome B.Rajkumar, Vincent
- [10] Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX[J]. HAEMATOLOGICA, 2018, 103 (12) : 2088 - 2096Dimopoulos, Meletios A.San-Miguel, JesusBelch, AndrewWhite, DarrellBenboubker, LotfiCook, GordonLeiba, MeravMorton, JamesHo, P. JoyKim, KihyunTakezako, NaokiMoreau, PhilippeKaufman, Jonathan L.Sutherland, Heather J.Lalancette, MarcMagen, HilaIida, ShinsukeKim, Jin SeokPrince, H. MilesCochrane, TaraOriol, AlbertBahlis, Nizar J.Chari, AjaiO'Rourke, LisaWu, KaidaSchecter, Jordan M.Casneuf, TinekeChiu, ChristopherSoong, DavidSasser, A. KateKhokhar, Nushmia Z.Avet-Loiseau, HerveUsmani, Saad Z.